Fragrance avoidance
No fragrance-linked caution surfaced in the current profile.
This ingredient does not currently read as a fragrance-linked driver in the published evidence and hazard profile.
- pharma
Hypromellose acetate succinate
CAS 71138-97-1
Concern score
Not assessed — no hazard data yet.
Why it's flagged
Route: ORAL; Dosage form: CAPSULE, DELAYED RELEASE; Maximum daily exposure: 89 mg
Regulation
No restrictions found. Hypromellose acetate succinate appears in these published regulatory listings.
- definition_level:complete
- definition_type:primary
- inactive_ingredient_database
- ingredient_type:unspecified ingredient
- substance_class:mixture
- substance_type:mixture
USFDAinactive ingredient database4 entries
- Route: ORAL; Dosage form: CAPSULE, DELAYED RELEASE; Maximum daily exposure: 89 mgSource →
- Route: ORAL; Dosage form: CAPSULE, EXTENDED RELEASE; Maximum daily exposure: 67 mgSource →
- Route: ORAL; Dosage form: TABLET; Maximum daily exposure: 4480 mgSource →
- Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Potency: 29 mgSource →
USFDAlisted in openFDA substanceopenFDA substance registry classifies this ingredient as mixture.
- openFDA substance registry classifies this ingredient as mixture.Source →
Evidence
No graded sources yet for Hypromellose acetate succinate. We publish evidence only once a source is linked and reviewed — this ingredient is in the catalog, but has not been assessed.
Suitability
Context-specific fit derived from published classifications and the current ingredient evidence profile.
Good fit
